Table 2.

Demographic and clinical characteristics of the TRS groups with and without admission

Variables	TRS with admission for FEP (n = 41)	TRS without admission for FEP (n = 38)	Statistic Values
General information
Age (years)	41.6 [10.2]	42.1 [12.1]	t = −0.197, P = 0.844
Sex: Male/Female (n)	26/15	21/17	Chi = 0.544, P = 0.461
Follow-up duration (days)	6040.2 [3424.8]	6247.1 [4005.1]	t = −0.247, P = 0.805
Age at onset (years)	24.1 [7.5]	23.9 [9.2]	t = 0.122, P = 0.903
Duration before meeting TRS (days)	2538.9 [2640.0]	3885.9 [3511.6]	t = −1.994, P = 0.050
Clinical index prior to treatment introduction
Premorbid social adjustment	4.27 [3.29]	5.18 [2.95]	t = −1.298, P = 0.198
DUP (months)	8.69 [17.6]	10.67 [15.39]	t = 0.512,
DUP Median	2.00	6.00	P = 0.610
Mode of onset: Acute/Insidious (n)	27/14	14/24	Chi = 6.65, P = 0.010
Clinical index related to FEP
Duration of initial hospital admission (days)	169.3 [261.4]	0 [0]	t = 3.992, P < 0.001
GAF after FEP	53.2 [16.8]	46.8 [16.0]	t = 1.716, P = 0.090
GAF > 70 (n)	8	3	–
CP-dose for FEP treatment (mg)	654.4 [427.5]	467.9 [374.6]	t = 2.034, P = 0.046

Abbreviations: CP chlorpromazine, DUP duration of untreated psychosis, FEP first-episode psychosis, TRS treatment-resistant schizophrenia